The Healthy Human Global Project - Hong Kong : a community-based cross-sectional study of a healthy Asian population The InnoHK Centre for Immunology & Infection (InnoHK C2i), established through a strategic partnership between The University of Hong Kong (HKU) and the Institut Pasteur,   together with the Institut Pasteur Milieu Interieur (MI) , FAMILY Cohort (HKU, School of Public Health)  and the Centre for Sports and Exercise (HKU CSE) have established  the  Healthy Hum

The Centre for Immunology & Infection is pleased to present the new edition of the Immunology Course, co‑organised with the HKU‑Pasteur Research Pole . Quantitative Immunology: From population to individual immunity NOVEMBER 15-20, 2026 Deadline for applications: 30 June 2026 The 12th HKU-Pasteur Immunology Course will explore the frontiers of quantitative immunology to describe the function of the immune system in health and disease at a population and individual level. Th

A new publication in Nature Lab Animal from C2i’s Alex Chin and Leo Poon demonstrates that the emerging SARS‑CoV‑2 Omicron EG.5 and JN.1 variants induce enhanced pathogenicity in K18‑hACE2 mice, overcoming limitations of early Omicron models and enabling more robust preclinical assessment of vaccines and antivirals.   Abstract : The reduced pathogenicity of early SARS-CoV-2 Omicron subvariants in human ACE2-expressing K18-hACE2 mice has posed challenges for assessing vacci

Join us on Thursday 26 March for a seminar from Professor Zhiyong Xi , Michigan State University. Registration: https://docs.google.com/forms/d/e/1FAIpQLSc8nEWPEZFIQ_VUwP_F8IT1KSPwekNIE0shPrsyJ0COcLcy6w/viewform

Job Reference Number: C2i-126-Admin Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies. It is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, Paris, two major international leaders combining their expertise to establish this centre of excellence. C2i aims

Reference Number: C2i125-RP2 The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.   It is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, Paris, two major international leaders combining their expertise to establish this centre of excellence. C2i aims

The vaccine not only prevents severe disease, but also effectively blocks viral transmission in animal models, offering a promising strategy for pandemic preparedness against future coronavirus threats. A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate, cb1, capable of generating broad immunity against a wide range of beta-coronaviruses with a single intranasal dose. The vaccine not on

Job Reference Number: C2i124-RP1 The Centre for Immunology & Infection (C2i) is a premier research institute focused on advancing biomarker discovery and the development of next-generation vaccines and therapeutic strategies. Founded through a strategic partnership of over 20 years between the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) and the Institut Pasteur in Paris, C2i integrates world-class expertise in biomedical science to drive innovation in pub

Job Reference Number: C2i123-RP3 The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.   It is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, Paris, two major international leaders combining their expertise to establish this centre of excellence.   C2i

Job Reference Number: C2i122-Admin The Centre for Immunology & Infection Limited (C2i) is a premier research institute focused on advancing biomarker discovery and the development of next-generation vaccines and therapeutic strategies. Founded through a strategic partnership of over 20 years between the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) and the Institut Pasteur in Paris, C2i integrates world-class expertise in biomedical science to drive innovat

Job Reference Number: C2i121-RP4 The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.   It is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, Paris, two major international leaders combining their expertise to establish this centre of excellence.   C2i

Job reference number: C2i120-RP1 Company Overview The Centre for Immunology & Infection (C2i) is a premier research institute focused on advancing biomarker discovery and the development of next-generation vaccines and therapeutic strategies. Founded through a strategic partnership of over 20 years between the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) and the Institut Pasteur in Paris, C2i integrates world-class expertise in biomedical science to drive

Job Reference Number: C2i119-RP2   The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.   It is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, Paris, two major international leaders combining their expertise to establish this centre of excellence. C2i

Job Reference Number: C2i118-RP4 The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.   It is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, Paris, two major international leaders combining their expertise to establish this centre of excellence.   C2i

The Centre for Immunology & Infection (C2i) is organising a Symposium as part of the 25 th  Anniversary of the HKU-Pasteur Research Pole week celebrating the long-lasting partnership between the University of Hong Kong (HKU) and the  Institut Pasteur .   The event will feature an overview of the past five years since the implementation of our center, highlighting key milestones and achievements. We will also discuss the next phase of development for C2i 2.0, which aims to enh

Professor   Michael Chan , Lead Scientist at C2i and CEO of C2iTech ,   was featured on RTHK's "Under the Sun" (太陽底下新鮮事) radio show, diving deep into the fascinating realm of organoid development! From lab breakthroughs to real-world impacts on medicine: https://www.rthk.hk/radio/radio1/programme/underthesun

We are delighted to share that C2iTech has been invited to attend the HKU Innovation Week 2025 and the TSSSU Ceremony! 🎉 As proud recipients for the 2024/2025 and 2025/2026 cycles, we look forward to showcasing our innovations and connecting with fellow leaders in technology and entrepreneurship. More info about the HKU Innovation Week: https://tec.hku.hk/innovation-week/ Join us as we drive the future of innovation!

The InnoHK Centre for Immunology & Infection Limited (C2i) and its spin-off C2iTech Limited have signed a Memorandum of Understanding (MOU) with Guangzhou Jingke Biotech Co., Ltd. and Shenzhen Jingke Biotech Co., Ltd. to advance patient-derived organoid (PDO) technologies for personalized oncology. The signing parties were represented by Professor Leo Poon , Managing Director, C2i; Professor Michael Chan , CEO, C2iTech; Mr. Sheng Li, Chairman, Jingke Biotech Group, and Profes

C2i is co-organizing a seminar with the HKUMed School of Public Health presented by  Professor Anna-Bella Failloux (Institut Pasteur,...

On the occasion of a joint seminar celebrating their partnership established in 2023, the Centre for Immunology & Infection Limited (C2i)...